Merck & Co
MRK
The Kroger Co.
KR
Eli Lilly and Co
LLY
UnitedHealth
UNH
Exxon Mobil
XOM
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -88.72%23.77M | -44.20%90.61M | -19.13%27.25M | 39.59%-15.23M | -297.66%-78.86M | 4,630.05%210.78M | 267.65%162.4M | 153.38%33.69M | -25.2M | 39.9M |
Net income from continuing operations | 86.92%-20.52M | 313.91%15.4M | 93.10%-8.98M | 602.86%19.44M | -108.23%-46.39M | -189.26%-156.84M | 87.30%-7.2M | -466.27%-130.12M | --2.77M | ---22.28M |
Operating gains losses | 3,575.36%12.83M | 125.66%156K | -118.04%-79K | -415.79%-98K | 2,288.10%12.85M | -92.41%349K | 39.20%-608K | -92.14%438K | ---19K | --538K |
Depreciation and amortization | 1.06%204.48M | 7.58%54.88M | -0.33%50.61M | -0.27%50.07M | -2.83%48.92M | -0.80%202.34M | -4.31%51.01M | -0.52%50.77M | --50.21M | --50.35M |
Deferred tax | 50.76%-25.91M | 111.62%1.87M | 298.70%21.48M | -40.97%-17.53M | -138.21%-31.73M | -88.23%-52.63M | -19.83%-16.07M | -22.27%-10.81M | ---12.43M | ---13.32M |
Other non cash items | -52.97%9.57M | -78.43%1.05M | -34.37%3.02M | -73.13%1.36M | -28.76%4.14M | -12.06%20.34M | -22.65%4.86M | -4.50%4.6M | --5.08M | --5.8M |
Change In working capital | -269.39%-270.07M | -111.71%-14.28M | -160.14%-65.59M | -10.84%-90.32M | -1,105.80%-99.89M | 171.03%159.44M | 202.44%121.94M | 195.52%109.05M | ---81.49M | --9.93M |
-Change in receivables | -40.70%-179.04M | -45.72%-15.04M | -346.82%-51.47M | 105.95%3.05M | -113.89%-115.58M | 15.43%-127.25M | 67.17%-10.32M | 78.24%-11.52M | ---51.37M | ---54.04M |
-Change in inventory | -925.24%-236.51M | -559.98%-162.25M | -728.84%-103.99M | 97.65%-765K | -55.95%30.49M | 121.74%28.66M | 79.94%-24.58M | 148.73%16.54M | ---32.51M | --69.21M |
-Change in prepaid assets | 121.76%7.6M | 128.97%10.07M | -8.69%-24.21M | 243.00%12.82M | -71.31%8.92M | -43.74%-34.9M | -162.62%-34.74M | -298.48%-22.27M | ---8.97M | --31.08M |
-Change in payables and accrued expense | -47.00%158.63M | -22.77%153.1M | -2.42%118.09M | -797.39%-90.74M | 33.85%-21.83M | 242.31%299.28M | 280.06%198.24M | 494.56%121.02M | --13.01M | ---33M |
-Change in other working capital | -226.11%-20.74M | 97.73%-151K | -175.99%-4.02M | -784.94%-14.69M | 43.33%-1.89M | -19.64%-6.36M | -68.28%-6.66M | 167.34%5.29M | ---1.66M | ---3.33M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -88.72%23.77M | -44.20%90.61M | -19.13%27.25M | 39.59%-15.23M | -297.66%-78.86M | 4,630.05%210.78M | 267.65%162.4M | 153.38%33.69M | ---25.2M | --39.9M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -4.32%-140.24M | 7.30%-15.78M | 34.44%-35.83M | -27.35%-57.69M | -77.16%-30.94M | -396.40%-134.43M | -111.82%-17.02M | -117.23%-54.65M | -45.3M | -17.46M |
Net PPE purchase and sale | -10.05%-80.91M | 9.05%-15.31M | -11.98%-20.04M | -13.34%-23.74M | -22.25%-21.82M | -4.87%-73.53M | 5.52%-16.83M | 4.07%-17.9M | ---20.95M | ---17.85M |
Net business purchase and sale | 5.17%-59.8M | 92.36%-42K | 56.42%-16.14M | -34.37%-34.22M | ---9.39M | -155.64%-63.06M | -100.34%-550K | -453.72%-37.04M | ---25.46M | --0 |
Net other investing changes | -78.02%473K | -217.96%-427K | 21.62%360K | -75.88%268K | -28.98%272K | 0.80%2.15M | -78.84%362K | 53.37%296K | --1.11M | --383K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -4.32%-140.24M | 7.30%-15.78M | 34.44%-35.83M | -27.35%-57.69M | -77.16%-30.94M | -396.40%-134.43M | -111.82%-17.02M | -117.23%-54.65M | ---45.3M | ---17.46M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 314.08%164.65M | 65.58%-49.55M | -8.50%19.53M | -43.46%39.91M | 722.01%154.76M | -4.20%-76.91M | -191.27%-143.95M | -72.47%21.34M | 70.58M | -24.88M |
Net issuance payments of debt | -1,154.01%-829.36M | 63.99%-47.85M | 13.12%24M | -40.97%41.63M | -3,292.61%-847.13M | 4.05%-66.14M | -172.45%-132.91M | -73.81%21.21M | --70.53M | ---24.97M |
Net common stock issuance | 160,843.85%1.04B | --0 | --0 | ---325K | --1.05B | ---650K | ---325K | -164.23%-325K | --0 | --0 |
Proceeds from stock option exercised by employees | 116.33%1.54M | 110.04%1M | -71.96%127K | 621.43%404K | --0 | -4,117.95%-9.4M | -9,109.01%-10M | --453K | --56K | --89K |
Net other financing activities | -7,192.76%-52.36M | ---2.7M | ---4.6M | ---1.8M | ---43.26M | 85.96%-718K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 314.08%164.65M | 65.58%-49.55M | -8.50%19.53M | -43.46%39.91M | 722.01%154.76M | -4.20%-76.91M | -191.27%-143.95M | -72.47%21.34M | --70.58M | ---24.88M |
Net cash flow | ||||||||||
Beginning cash position | -4.09%13.07M | 209.02%35.97M | 122.34%25.03M | 419.11%58.04M | -4.09%13.07M | -70.84%13.63M | -26.91%11.64M | -57.82%11.26M | --11.18M | --13.63M |
Current changes in cash | 8,750.27%48.18M | 1,667.83%25.28M | 2,743.12%10.95M | -43,534.21%-33.01M | 1,936.85%44.97M | 98.32%-557K | 162.23%1.43M | 103.58%385K | --76K | ---2.45M |
End cash Position | 368.62%61.25M | 368.62%61.25M | 209.02%35.97M | 122.34%25.03M | 419.11%58.04M | -4.09%13.07M | -4.09%13.07M | -26.91%11.64M | --11.26M | --11.18M |
Free cash flow | -141.63%-57.14M | -48.27%75.3M | -54.39%7.2M | 15.57%-38.97M | -556.58%-100.68M | 283.58%137.26M | 226.93%145.57M | 119.31%15.79M | ---46.15M | --22.05M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |